Apostolia Tsimberidou

Dr. Apostolia Tsimberidou is a professor at MD Anderson Cancer Center who has led landmark prospective analyses of molecular tumor board-guided treatment. She directed the IMPACT2 study demonstrating that patients receiving matched targeted therapy had significantly improved response rates and progression-free survival compared to unmatched treatment. Her work provides robust evidence for the clinical benefit of molecular tumor board recommendations in refractory solid tumors.